<b>Methods:</b> A comprehensive search of trials of PD-1/PD-L1 inhibitors in EC, GC and CRC was performed in Chinese and English medical databases with a cut-off date of 1 July 2022. Here, PDCD1 is linked to colorectal carcinoma.